Fund HoldingsPivotal bioVenture Partners Investment Advisor LLC

Total Portfolio Value
$155.58M
Total Bought
$13.93M
Total Sold
$271.04M
Net Transaction
-$257.11M
Filing Period:
Securities
SharesValue ($K)
Q4 2023
Q1 2024
Change
Q4 2023
Q1 2024
Weight (%)
Change
INOZYME PHARMA INC4,494,8514,494,851019,14834,43122.13%+15,282
ARCUTIS BIOTHERAPEUTICS INC(ARQT)1,910,0092,028,008+117,9996,16920,09812.92%+13,928
VAXCYTE INC(PCVX)793,036793,036049,80354,17234.82%+4,370
BOLT BIOTHERAPEUTICS INC1,891,4671,891,46702,1182,6481.70%+530
ALIGOS THERAPEUTICS INC743,215743,21504937280.47%+235
VIGIL NEUROSCIENCE INC560,595560,59501,8951,9121.23%+17
IO BIOTECH INC864,197864,19701,6251,4950.96%-130
EXSCIENTIA PLC770,500770,50004,9394,4072.83%-532
RALLYBIO CORP2,404,6442,404,64405,7474,4492.86%-1,299
OCULIS HOLDING AG1,888,7881,595,918-292,87021,21119,23112.36%-1,980
FUSION PHARMACEUTICALS INC1,560,982563,385-997,59715,00112,0117.72%-2,990
GRACELL BIOTECHNOLOGIES INC1,375,0000-1,375,00013,8050-13,805
KARUNA THERAPEUTICS INC797,0080-797,008252,2610-252,261
Page 1 of 1